{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:18:07Z","timestamp":1783034287435,"version":"3.54.6"},"reference-count":9,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Nucl Med"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the following case study, we evaluate a prostate cancer patient with persistent biochemical relapse and negative conventional imaging. Following interdisciplinary team discussion, it is decided to assess the patient by a 11C-Choline and 68Ga-PSMA positron emission tomography\/computed tomography (PET\/CT) scan. Notably, doubtful findings due to physiological urinary activity in the 68Ga-PSMA-11 PET\/CT scan were clarified with PET\/CT\u2013magnetic resonance imaging (MRI) images. The added value of the trimodality PET\/CT\u2013MRI system was very useful in detecting recurrence in a case classified as indeterminate by means of PET\/CT alone at prostatic fossa.<\/jats:p>","DOI":"10.1055\/s-0045-1812055","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:30:17Z","timestamp":1759617017000},"page":"178-181","source":"Crossref","is-referenced-by-count":1,"title":["The Trimodality PET\/CT\u2013MRI (3.0 T) System with a Dedicated Shuttle Detects Local Recurrence in a Case Classified as Indeterminate by Means of PSMA PET\/CT Alone at Prostatic Fossa"],"prefix":"10.1055","volume":"25","author":[{"given":"Gerardo Gabriel","family":"dos Santos Loureiro","sequence":"additional","affiliation":[{"name":"Uruguayan Centre of Molecular Imaging, Montevideo, Uruguay"},{"name":"Nuclear Medicine and Molecular Imaging Centre, Hospital de Cl\u00ednicas, Universidad de la Rep\u00fablica, Montevideo, Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Gambini Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Uruguayan Centre of Molecular Imaging, Montevideo, Uruguay"},{"name":"Nuclear Medicine and Molecular Imaging Centre, Hospital de Cl\u00ednicas, Universidad de la Rep\u00fablica, Montevideo, Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Rodriguez","family":"Parodi","sequence":"additional","affiliation":[{"name":"Uruguayan Centre of Molecular Imaging, Montevideo, Uruguay"},{"name":"Nuclear Medicine and Molecular Imaging Centre, Hospital de Cl\u00ednicas, Universidad de la Rep\u00fablica, Montevideo, Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Alonso N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Uruguayan Centre of Molecular Imaging, Montevideo, Uruguay"},{"name":"Nuclear Medicine and Molecular Imaging Centre, Hospital de Cl\u00ednicas, Universidad de la Rep\u00fablica, Montevideo, Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"issue":"02","key":"ref1","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"921674","DOI":"10.1155\/2012\/921674","article-title":"Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy","volume":"2012","author":"S Kosuri","year":"2012","journal-title":"Adv Urol"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3413\/nukmed-0194","article-title":"Three-phase 18F-fluorocholine PET\/CT in the evaluation of prostate cancer recurrence","volume":"48","author":"Ch Steiner","year":"2009","journal-title":"Nuklearmedizin"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00259-016-3490-6","article-title":"Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET\/CT","volume":"44","author":"J Schwenck","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","article-title":"68Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0","volume":"44","author":"W P Fendler","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00259-013-2660-z","article-title":"Comparison of PET\/CT and PET\/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience","volume":"41","author":"A Afshar-Oromieh","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2214\/AJR.13.11046","article-title":"Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis","volume":"202","author":"M de Rooij","year":"2014","journal-title":"AJR Am J Roentgenol"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10334-012-0344-5","article-title":"PET-MR imaging using a tri-modality PET\/CT-MR system with a dedicated shuttle in clinical routine","volume":"26","author":"P Veit-Haibach","year":"2013","journal-title":"Magn Reson Mater Biol Phys Med"},{"issue":"05","key":"ref9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","article-title":"Simultaneous 68Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer","volume":"70","author":"M Eiber","year":"2016","journal-title":"Eur Urol"}],"container-title":["World Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1812055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:38:03Z","timestamp":1783031883000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0045-1812055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":9,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2026,7,2]]},"published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0045-1812055","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1450-1147","1607-3312"],"issn-type":[{"value":"1450-1147","type":"print"},{"value":"1607-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]}}}